Understanding Stakeholders' Perspectives to Increase COVID-19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions.
Journal
Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
09
05
2023
received:
10
01
2023
accepted:
08
06
2023
pmc-release:
13
12
2024
medline:
30
11
2023
pubmed:
13
6
2023
entrez:
13
6
2023
Statut:
ppublish
Résumé
Disparities in COVID-19 vaccine and booster uptake persist. This study aimed to obtain perspectives from community and physician stakeholders on COVID-19 vaccine and booster hesitancy and strategies to promote vaccine uptake among Black individuals with rheumatic and musculoskeletal conditions. We invited community leaders and physicians in greater Boston and Chicago to participate in semi-structured interviews using a moderator guide developed a priori. Participants were queried about how to best address vaccine hesitancy, strategies to target high-risk populations, and factors to identify future community leaders. Interviews were audio recorded, transcribed verbatim, and analyzed thematically using Dedoose. A total of 8 physicians and 12 community leaders participated in this study between November 2021 and October 2022. Qualitative analyses revealed misinformation/mixed messaging and mistrust, with subthemes including conspiracy theories, concerns regarding vaccine development and function, racism and historical injustices, and general mistrust of health care systems as the top cited reasons for COVID-19 vaccine hesitancy. Participants also shared demographic-specific differences, such as race, ethnicity, age, and gender that influenced the identified themes, with emphasis on COVID-19 vaccine access and apathy. Strategies for community-based vaccine-related information dissemination included personal storytelling with an iterative and empathetic approach, while recognizing the importance of protecting community leader well-being. To increase vaccine uptake among Black individuals with rheumatic conditions, strategies should acknowledge and respond to racial/ethnic and socioeconomic injustices that engender vaccine hesitancy. Messaging should be compassionate, individually tailored, and recognize heterogeneity in experiences and opinions. Results from these analyses will inform a planned community-based intervention in Boston and Chicago.
Identifiants
pubmed: 37309724
doi: 10.1002/acr.25172
pmc: PMC10716359
mid: NIHMS1909138
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2508-2518Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR080089
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01AR080089
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01AR080089
Pays : United States
Informations de copyright
© 2023 American College of Rheumatology.
Références
BMC Rheumatol. 2022 Nov 29;6(1):76
pubmed: 36443813
Rheumatology (Oxford). 2023 Apr 3;62(4):1460-1466
pubmed: 36069664
Lancet. 2017 Apr 8;389(10077):1453-1463
pubmed: 28402827
Am J Public Health. 2021 Mar;111(3):366-368
pubmed: 33301352
Lupus. 2019 Oct;28(12):1441-1451
pubmed: 31594456
Lancet Rheumatol. 2021 Apr;3(4):e241-e243
pubmed: 33655220
Nature. 2020 Apr;580(7803):306
pubmed: 32231320
Am J Public Health. 1991 Feb;81(2):168-71
pubmed: 1990853
MMWR Morb Mortal Wkly Rep. 2022 Jun 10;71(23):757-763
pubmed: 35679179
Lancet Rheumatol. 2021 Apr;3(4):e243-e245
pubmed: 33655219
MMWR Morb Mortal Wkly Rep. 2022 Sep 02;71(35):1121-1125
pubmed: 36048732
Ann Rheum Dis. 2021 Jul;80(7):953-954
pubmed: 33622689
Ecohealth. 2021 Mar;18(1):44-60
pubmed: 34086129
Arthritis Care Res (Hoboken). 2023 Jan;75(1):44-52
pubmed: 35381123
Int J Rheum Dis. 2022 Sep;25(9):1046-1052
pubmed: 35773944
Health Psychol. 2023 Aug;42(8):531-540
pubmed: 36066860
Soc Sci Med. 2021 Feb;270:113684
pubmed: 33485008
Am J Health Promot. 2022 Nov;36(8):1304-1315
pubmed: 35506153
Immun Inflamm Dis. 2022 Mar;10(3):e589
pubmed: 35099852
Clin Exp Med. 2023 Jun;23(2):457-463
pubmed: 35612692
BMC Public Health. 2023 Jan 12;23(1):88
pubmed: 36631819
JAMA Netw Open. 2021 Sep 1;4(9):e2127582
pubmed: 34591103
Arthritis Rheumatol. 2021 Oct;73(10):e60-e75
pubmed: 34346564
Lancet Rheumatol. 2022 Nov;4(11):e765-e774
pubmed: 36118532
J Health Care Poor Underserved. 2010 Aug;21(3):879-97
pubmed: 20693733
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207
pubmed: 33196555
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
RMD Open. 2019 Sep 19;5(2):e001041
pubmed: 31673420
J Gen Intern Med. 2021 Nov;36(11):3629-3631
pubmed: 34021446
Arthritis Rheumatol. 2021 Mar;73(3):374-380
pubmed: 33146001
PLoS One. 2022 May 3;17(5):e0268020
pubmed: 35503797
Vaccines (Basel). 2021 Jul 09;9(7):
pubmed: 34358184
N Engl J Med. 2020 Nov 26;383(22):e121
pubmed: 33064382